| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, Chairman
2 companies
Broshy Eran is a Director at Theravance Biopharma, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 2 buys and 5 sells.
Estimated insider holdings value: $1.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 26, 2025 | TBPH Theravance Biopharma, Inc. | Director | Sale+OE | 29,501 | $20.00 | $590,020.00 | -21.9% | -4.5% | - | |
| Nov 11, 2025 | TBPH Theravance Biopharma, Inc. | Director | Sale+OE | 59,000 | $18.11 | $1,068,250.00 | -27.7% | +5.4% | - | |
| Aug 22, 2023 | CERT Certara, Inc. | Director | Buy | 5,000 | $15.81 | $79,057.90 | +26.4% | -6.1% | -17.7% |